263 related articles for article (PubMed ID: 19498198)
1. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.
Rajamani K; Chaturvedi S; Jin Z; Homma S; Brey RL; Tilley BC; Sacco RL; Thompson JL; Mohr JP; Levine SR;
Stroke; 2009 Jul; 40(7):2337-42. PubMed ID: 19498198
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
4. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale.
DeSimone CV; Friedman PA; Noheria A; Patel NA; DeSimone DC; Bdeir S; Aakre CA; Vaidya VR; Slusser JP; Hodge DO; Ackerman MJ; Rabinstein AA; Asirvatham SJ
Circulation; 2013 Sep; 128(13):1433-41. PubMed ID: 23946264
[TBL] [Abstract][Full Text] [Related]
5. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Homma S; DiTullio MR; Sacco RL; Sciacca RR; Mohr JP;
Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117
[TBL] [Abstract][Full Text] [Related]
6. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
Mazzucco S; Li L; Rothwell PM
JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
[TBL] [Abstract][Full Text] [Related]
8. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
[TBL] [Abstract][Full Text] [Related]
10. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.
Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ
JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
Amory CF; Levine SR; Brey RL; Gebregziabher M; Tuhrim S; Tilley BC; Simpson AC; Sacco RL; Mohr JP;
Cerebrovasc Dis; 2015; 40(5-6):293-300. PubMed ID: 26513489
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic Stroke.
Shih EK; Beslow LA; Natarajan SS; Falkensammer CB; Messé SR; Ichord RN
Neurology; 2021 Nov; 97(21):e2096-e2102. PubMed ID: 34649876
[TBL] [Abstract][Full Text] [Related]
14. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP;
Circulation; 2002 Jun; 105(22):2625-31. PubMed ID: 12045168
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.
Cujec B; Mainra R; Johnson DH
Can J Cardiol; 1999 Jan; 15(1):57-64. PubMed ID: 10024860
[TBL] [Abstract][Full Text] [Related]
17. Recurrence Risk in Patients with Cryptogenic Stroke, Patent Foramen Ovale, and Thrombophilia: A Systematic Review and Meta-Analysis.
Hviid CVB; Simonsen CZ; Hvas AM
Thromb Haemost; 2019 Nov; 119(11):1839-1848. PubMed ID: 31378004
[TBL] [Abstract][Full Text] [Related]
18. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP
J Am Coll Cardiol; 2003 Sep; 42(6):1066-72. PubMed ID: 13678932
[TBL] [Abstract][Full Text] [Related]
19. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
[TBL] [Abstract][Full Text] [Related]
20. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
